We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $42.5B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+0.33%
1 Year Est. Return
+18.19%
3 Year Est. Return
+63.85%
5 Year Est. Return
+89.78%
10 Year Est. Return
+309.54%
AUM
$40.2B
AUM Growth
-$933M
Cap. Flow
-$563M
Cap. Flow %
-1.4%
Top 10 Hldgs %
41.26%
Holding
326
New
14
Increased
66
Reduced
135
Closed
15

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$382M
2
ETN icon
Eaton
ETN
+$274M
3
NVDA icon
NVIDIA
NVDA
+$110M
4
LLY icon
Eli Lilly
LLY
+$40.2M
5
NOW icon
ServiceNow
NOW
+$32.3M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$194M
2
UNP icon
Union Pacific
UNP
+$185M
3
AZN icon
AstraZeneca
AZN
+$164M
4
MSFT icon
Microsoft
MSFT
+$81.1M
5
V icon
Visa
V
+$76.3M

Sector Composition

Rank Sector Weight
1 Technology 27.83%
2 Financials 19.19%
3 Consumer Staples 12.47%
4 Healthcare 10.91%
5 Energy 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GD icon
151
General Dynamics
GD
$96.5B
$2.1M 0.01%
7,721
WM icon
152
Waste Management
WM
$87.2B
$2.09M 0.01%
9,038
+1,726
+24% +$382K
SHAK icon
153
Shake Shack
SHAK
$2.57B
$2.09M 0.01%
23,718
BAC icon
154
Bank of America
BAC
$416B
$2.08M 0.01%
49,844
-31,353
-39% -$1.4M
TRV icon
155
Travelers Companies
TRV
$78.9B
$2.03M 0.01%
7,688
FCX icon
156
Freeport-McMoran
FCX
$99.6B
$1.99M ﹤0.01%
52,490
-756
-1% -$28.9K
GE icon
157
GE Aerospace
GE
$329B
$1.93M ﹤0.01%
9,644
+1,204
+14% +$237K
SYY icon
158
Sysco
SYY
$40B
$1.87M ﹤0.01%
24,935
-8,365
-25% -$613K
MAS icon
159
Masco
MAS
$13.7B
$1.86M ﹤0.01%
26,735
+1,834
+7% +$137K
LOW icon
160
Lowe's Companies
LOW
$111B
$1.79M ﹤0.01%
7,685
DHR icon
161
Danaher
DHR
$143B
$1.73M ﹤0.01%
8,454
+167
+2% +$36.5K
GS icon
162
Goldman Sachs
GS
$288B
$1.71M ﹤0.01%
3,135
+375
+14% +$226K
TSLA icon
163
Tesla
TSLA
$1.42T
$1.66M ﹤0.01%
6,421
+31
+0.5% +$10.3K
REGN icon
164
Regeneron Pharmaceuticals
REGN
$81.7B
$1.65M ﹤0.01%
2,600
-75
-3% -$51.6K
VOO icon
165
Vanguard S&P 500 ETF
VOO
$1.04T
$1.64M ﹤0.01%
3,187
+2,303
+261% +$1.24M
STT icon
166
State Street
STT
$51.7B
$1.64M ﹤0.01%
18,279
CCK icon
167
Crown Holdings
CCK
$12.2B
$1.45M ﹤0.01%
16,200
WMB icon
168
Williams Companies
WMB
$88B
$1.44M ﹤0.01%
24,056
+7,971
+50% +$456K
APH icon
169
Amphenol
APH
$194B
$1.42M ﹤0.01%
43,302
-1,490
-3% -$50.8K
FMX icon
170
Fomento Económico Mexicano
FMX
$41.3B
$1.38M ﹤0.01%
14,132
-3,000
-18% -$272K
WBA
171
DELISTED
Walgreens Boots Alliance
WBA
$1.36M ﹤0.01%
121,634
-4,900
-4% -$53.2K
AMP icon
172
Ameriprise Financial
AMP
$49.3B
$1.31M ﹤0.01%
2,716
TPR icon
173
Tapestry
TPR
$23.5B
$1.31M ﹤0.01%
18,566
-1,244
-6% -$94.1K
AMAT icon
174
Applied Materials
AMAT
$337B
$1.31M ﹤0.01%
9,000
KEX icon
175
Kirby Corp
KEX
$7.31B
$1.24M ﹤0.01%
12,278

Similar funds

Fayez Sarofim & Co's Q1 2025 Portfolio in Review

As of Q1 2025, Fayez Sarofim & Co held 326 positions worth $40.2B, down 2.3% from $41.1B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Fayez Sarofim & Co's Q1 2025 filing shows 14 new, 66 increased, 135 reduced and 15 closed positions. Its largest new stake was BNY Mellon Concentrated Growth ETF: 191,899 shares worth $0. The largest sale was UnitedHealth, an estimated $194M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Financials and Consumer Staples.

  • Fayez Sarofim & Co's largest Q1 2025 buy was BNY Mellon Concentrated Growth ETF: 191,899 shares worth $0.
  • Fayez Sarofim & Co added most to Meta Platforms (Facebook) in Q1 2025, an estimated $382M increase.
  • Fayez Sarofim & Co's biggest Q1 2025 reduction was UnitedHealth, cutting an estimated $194M.
  • Fayez Sarofim & Co fully exited Brookfield in Q1 2025, selling an estimated $1.16M.
  • Fayez Sarofim & Co's ten largest holdings make up 41% of its $40.2B portfolio in Q1 2025.
  • Fayez Sarofim & Co opened 14 new positions and closed 15 in Q1 2025.
  • Fayez Sarofim & Co's portfolio value fell 2.3% quarter-over-quarter to $40.2B.

Based on Fayez Sarofim & Co's 13F filing for Q1 2025, filed 12 May 2025.